Header cover image

Chinese Pharmaceuticals & Biotech Small Cap High Growth Stocks

UPDATED Jul 23, 2022

Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.

1 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
2873Guiyang Xintian PharmaceuticalLtdCN¥16.331.4%33.6%CN¥2.7bn/aPE25.4xE28.9%0.7%
Page 1 of 1